MERLIE SEDAN: Open Payments
NPI 1184758450 · ISSAQUAH, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 32 payments from 13 companies in 2025. Trend: 2023 $674 · 2024 $1,149 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $310 |
| GENZYME CORPORATION | 4 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| 3B Medical, Inc. | 3 | $52 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Fisher & Paykel Healthcare Inc | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
Products named: AIRSUPRA, DUPIXENT, LUNA, NEFFY, NUCALA, TEZSPIRE, XHANCE, FISHER & PAYKEL HEALTHCARE.
Industry payments across WA — which companies pay providers there.
